mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.085 |
0.07 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.55 |
0.07 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.07 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.082 |
0.07 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.086 |
0.07 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.07 |